The study will look at the safety and efficacy of Hip Innovation Technology’s system in total hip patients, according to a Jan. 18 news release. Results will be evaluated with clinical, radiologic and patient-reported outcomes.
The reverse hip replacement system is a metal-on-polyethylene reverse geometry hip prosthesis. It’s designed to improve stability at extended ranges of motion and reduce the risk of dislocation.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
